D. E. Shaw & Co »

Oruka Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 95k 19.23
2025-06-30 $758k 68k 11.21

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Deep Track Capital
Rtw Investments
Commodore Capital
Paradigm Biocapital Advisors
State Street Corporation
venBio Select Advisor
Perceptive Advisors
Polar Capital Holdings
Geode Capital Management

View all funds holding Oruka Therapeutics